ArticleCytoJournal2024

Exploring the efficacy and safety of anti-BCMA chimeric antigen receptor T-cell therapy for multiple myeloma: Systematic review and meta-analysis.

Jia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.